| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/25/2013 | WO2013057208A1 Compositions and methods for reducing the proliferation and viability of microbial agents |
| 04/25/2013 | WO2013057197A1 Process for the formylation of cefamandole |
| 04/25/2013 | WO2013057196A1 Process for the preparation of cefamandole nafate |
| 04/25/2013 | WO2013056453A1 Preparation method and application of injection for needleless injection |
| 04/25/2013 | WO2013056327A1 Cleaning solution for contact lenses |
| 04/25/2013 | WO2013056304A1 Influenza immunotherapy |
| 04/25/2013 | WO2013033004A3 Metalloenzyme inhibitor compounds |
| 04/25/2013 | WO2013030218A4 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 04/25/2013 | WO2013025834A3 Compositions and methods related to antibodies to staphylococcal protein a |
| 04/25/2013 | WO2013024494A3 Amorphous mixture of lopinavir and ritonavir co-precipitated on copovidone |
| 04/25/2013 | WO2013022550A3 Small molecule inhibitors of ebola and lassa fever viruses |
| 04/25/2013 | WO2013009844A3 C-3 substituted bicyclooctane based hiv protease inhibitors |
| 04/25/2013 | WO2013003410A3 Prevention and treatment of hiv infection |
| 04/25/2013 | WO2013001372A3 Methods and compositions for inhibition of activation of regulatory t cells |
| 04/25/2013 | WO2012162412A3 Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use |
| 04/25/2013 | US20130102898 Liposome including elastin-like polypeptides and use thereof |
| 04/25/2013 | US20130102690 Collagen-polysaccharide materials mimicking blood vessels, tissues and bones for medical, pharmaceutical and orthopedic applications, and processes for producing the same |
| 04/25/2013 | US20130102601 Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | US20130102600 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | US20130102589 Novel Compound for the Treatment of Hepatitis C |
| 04/25/2013 | US20130102558 Methods for Treating HCV |
| 04/25/2013 | US20130102557 Methods for Treating HCV |
| 04/25/2013 | US20130102545 Temperature dependent activation of catalytic nucleic acids for controlled active substance release |
| 04/25/2013 | US20130102526 Methods for Treating HCV |
| 04/25/2013 | US20130102525 Methods for Treating HCV |
| 04/25/2013 | US20130102523 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use |
| 04/25/2013 | US20130101653 Methods and materials for reducing the risk of infections |
| 04/25/2013 | US20130101627 Composition with extracts from olive leaf, yarrow and rosemary for treating human diseases and conditions |
| 04/25/2013 | US20130101620 Recombinant varicella-zoster virus |
| 04/25/2013 | US20130101619 Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens |
| 04/25/2013 | US20130101612 Vaccine for enveloped viruses |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | US20130101577 Extended Soluble PH20 Polypeptides and uses thereof |
| 04/25/2013 | US20130101529 Composition for treating and/or preventing periodontal disease |
| 04/25/2013 | US20130098357 Cerivastatin to treat pulmonary disorders |
| 04/25/2013 | CA2852857A1 Adjuvanted influenza b virus vaccines for pediatric priming |
| 04/25/2013 | CA2852843A1 Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | CA2852750A1 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | CA2852607A1 Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones |
| 04/25/2013 | CA2852474A1 Antibodies directed against influenza |
| 04/25/2013 | CA2852214A1 Anti-diabetic aminosteroid derivatives |
| 04/25/2013 | CA2851396A1 Novel phenicol antibacterials |
| 04/25/2013 | CA2849564A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/24/2013 | EP2583972A1 Therapeutic agent for inflammatory diseases containing adenosine n1-oxide as active ingredient |
| 04/24/2013 | EP2583969A2 Novel rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients |
| 04/24/2013 | EP2583962A2 Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating aids, containing same as active ingredient |
| 04/24/2013 | EP2583684A2 Peptide having antimicrobial or anti-inflammatory activity and pharmaceutical composition containing same as an active ingredient |
| 04/24/2013 | EP2583681A1 Oral veterinary composition for salmonids, comprising 1-beta-d-ribofuranosyl-1h-1,2,4-triazole-3-carboxamide and use thereof for the treatment of infectious salmon anaemia (isa) in salmonids |
| 04/24/2013 | EP2583680A2 Mono (PSI-7977) or combination treatment of DAAs for use in treating HCV |
| 04/24/2013 | EP2583678A2 Small molecule immunopotentiators and assays for their detection |
| 04/24/2013 | EP2583677A2 Methods for treating HCV comprising at least two direct acting antiviral agent, ribavirin but not interferon. |
| 04/24/2013 | EP2583099A2 Pla2g16 as a target for antiviral compounds |
| 04/24/2013 | EP2582721A1 Antibodies useful in passive influenza immuization |
| 04/24/2013 | EP2582712A2 Linked purine pterin hppk inhibitors useful as antibacterial agents |
| 04/24/2013 | EP2582702A1 Pyrazolopyrimidine kinase inhibitors |
| 04/24/2013 | EP2582700A2 Respiratory formulations and compounds for use therein |
| 04/24/2013 | EP2582433A2 Methods |
| 04/24/2013 | EP2582432A1 Ureido-pyrazole derivatives for use in the treatment of respiratory syncitial virus (rsv) infection |
| 04/24/2013 | EP2582393A1 Dose selection of adjuvanted synthetic nanocarriers |
| 04/24/2013 | EP2301524B1 Inhalable aztreonam without arginine for treatment and prevention of pulmonary bacterial infections |
| 04/24/2013 | CN1935141B Use of descarboethoxyloratadine or its pharmaceutical salts in preparing medicine for treating urticaria |
| 04/24/2013 | CN1869061B Peptidomimetic protease inhibitors |
| 04/24/2013 | CN1758923B Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria |
| 04/24/2013 | CN1653050B Opioid and opioid-like compounds and uses thereof |
| 04/24/2013 | CN103069000A Eggshell membrane solubilization method using enzymes |
| 04/24/2013 | CN103068819A Heterocyclic antiviral compounds |
| 04/24/2013 | CN103068381A Medicinal agent for prevention and/or treatment of hepatocellular carcinoma |
| 04/24/2013 | CN103060377A Lentiviral vector of pseudotyped lymphocytic choriomeningitis virus glycoprotein |
| 04/24/2013 | CN103060356A Duck plague virus deficient in g E gene transfer vector and constructing method thereof |
| 04/24/2013 | CN103060343A Duck plague virus g E protein genes and application thereof |
| 04/24/2013 | CN103060325A Antisense nucleic acid and peptide nucleic acid PNA resisting against porcine epidemic diarrhea virus PEDV |
| 04/24/2013 | CN103060324A Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 04/24/2013 | CN103060278A Asia 1 type foot and mouth disease virus acid resistant mutant strains, capsid protein carried by same and encoding gene thereof and application |
| 04/24/2013 | CN103060222A Bacillus subtilis B27 with probiotic effect and application thereof |
| 04/24/2013 | CN103060221A Culture medium adopting continuous enrichment culture for mycoplasma gaujseptium and preparation method |
| 04/24/2013 | CN103060220A Low-serum culture medium for efficiently culturing mycoplasma hyopneumoniae and preparation method thereof |
| 04/24/2013 | CN103059295A Hydrophobic-modified polyethyleneimine and application thereof as protein carrier |
| 04/24/2013 | CN103059157A Phyllanthus urinaria L polysaccharide component extraction and separation method |
| 04/24/2013 | CN103059142A Recombinant protein of antigen to porcine circovirus and antigen to porcine reproductive and respiratory syndrome virus, and preparation method and application of recombinant protein |
| 04/24/2013 | CN103059139A Methicillin-resistant Staphylococcus aureus (MRSA) vaccine recombinant proteantigen I12C, and preparation method and application thereof |
| 04/24/2013 | CN103059133A Monoclonal antibody and antibody composition for neutralizing canine distemper virus (CDV) |
| 04/24/2013 | CN103059131A Method for preparing bivalent yolk antibody for preventing and treating duck virus hepatitis I and III |
| 04/24/2013 | CN103059124A Recombined porcine interferon Gamma, coding gene thereof and expressing method |
| 04/24/2013 | CN103059123A Recombinant porcine interferon beta1, encoding gene and expression method thereof |
| 04/24/2013 | CN103059122A Recombined porcine interferon alpha 1, as well as gene encoding gene and expression method thereof |
| 04/24/2013 | CN103059106A Polymixin derivative and application thereof |
| 04/24/2013 | CN103059103A Specific CD4+T cell epitope peptide of Hantaan virus nucleoprotein |
| 04/24/2013 | CN103059102A Polypeptide for inhibiting hepatitis C viruses (HCVs) from infecting cells, and its application |
| 04/24/2013 | CN103059088A Dammarane saponin derivatives with novel structure as well as preparation method and anti-microbial application thereof |
| 04/24/2013 | CN103059084A Acetyl isovaleryl tylosin amide, preparation method and application |
| 04/24/2013 | CN103059074A Glucosamine peptidomimetic compound as well as preparation method and application thereof |
| 04/24/2013 | CN103059045A Novel amoxicillin sodium and clavulanate potassium compound and pharmaceutical composition thereof |
| 04/24/2013 | CN103059042A Thiophene derivative and application thereof to medicine |
| 04/24/2013 | CN103059022A Purine derivative and pharmaceutical application thereof |
| 04/24/2013 | CN103059014A Novel heteroaryl amino derivative |
| 04/24/2013 | CN103059010A 1,4-benzoxazinone-1,2,3-triazole compound having antifungal activity, and its preparation method |
| 04/24/2013 | CN103059006A Chrysin-1,2,3-triazole compound having antibacterial activity, and its preparation method |
| 04/24/2013 | CN103059003A Benzimidazole-1,2,3-triazole compound having antifungal activity, and its preparation method |
| 04/24/2013 | CN103058994A Urea derivative and medicinal application thereof |
| 04/24/2013 | CN103058943A Diniconazole-1,2,3-triazole compound having antibacterial activity, and its preparation method |